New hope for Tough-to-Treat colon cancer: experimental combo targets rare mutation
NCT ID NCT07229846
Summary
This study is testing a new combination of drugs as the first treatment for people with advanced colorectal cancer that has spread and has a specific genetic change called BRAF V600E. The treatment combines an experimental immunotherapy drug with standard chemotherapy and another cancer drug. Researchers want to see if this combination is safe and can shrink tumors and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin Medical University Cancer Hosptital
Harbin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.